Abstract
Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is a technique of external beam radiation that delivers precisely targeted, ablative doses to extracranial sites. It has become an integral component of the management of early-stage non-small cell lung cancer (NSCLC). In this review, we discuss the technology and techniques used in treatment planning and delivery, the efficacy and toxicity of SBRT for medically inoperable early-stage NSCLC, and the preliminary investigations into the role of SBRT for operable early-stage NSCLC.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 274-279 |
| Number of pages | 6 |
| Journal | Cancer Journal (United States) |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 26 2016 |
Keywords
- Non-small cell lung cancer
- Stereotactic ablative radiotherapy
- Stereotactic body radiation therapy
ASJC Scopus subject areas
- Cancer Research
- Oncology
Fingerprint Dive into the research topics of 'Stereotactic body radiation therapy for early-stage lung cancer'. Together they form a unique fingerprint.
Cite this
Maquilan, G., & Timmerman, R. (2016). Stereotactic body radiation therapy for early-stage lung cancer. Cancer Journal (United States), 22(4), 274-279. https://doi.org/10.1097/PPO.0000000000000204